# Mark S. Silverberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-s-silverberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,726 |
| Field | Inflammatory Bowel Disease |
| h-index | 90 |
| i10-index | 255 |
| Last Known Institution | Mount Sinai Hospital |
| OpenAlex ID | https://openalex.org/A5003048730 |
| ORCID iD | https://orcid.org/0000-0002-9534-1419 |
| Works | 644 |

## Researcher papers

- [Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology](https://scholariq.org/papers/toward-an-integrated-clinical-molecular-and-serological-classification-of/)
- [A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene](https://scholariq.org/papers/a-genome-wide-association-study-identifies-i-il23r-i-as-an-inflammatory-bowel/)
- [Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease](https://scholariq.org/papers/genome-wide-association-defines-more-than-30-distinct-susceptibility-loci-for/)
- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47](https://scholariq.org/papers/meta-analysis-identifies-29-additional-ulcerative-colitis-risk-loci-increasing/)
- [Common variants at five new loci associated with early-onset inflammatory bowel disease](https://scholariq.org/papers/common-variants-at-five-new-loci-associated-with-early-onset-inflammatory-bowel/)
- [IL-12 and IL-23 pathway inhibition in inflammatory bowel disease](https://scholariq.org/papers/il-12-and-il-23-pathway-inhibition-in-inflammatory-bowel-disease/)
- [Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting](https://scholariq.org/papers/management-of-patients-with-crohn-s-disease-and-ulcerative-colitis-during-the/)
- [Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies](https://scholariq.org/papers/serologic-response-to-messenger-rna-coronavirus-disease-2019-vaccines-in/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Mount Sinai Hospital](https://scholariq.org/institutions/mount-sinai-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.